Home LiteratureArticle Details
PMID: 17996079 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays.

BMC bioinformatics ·Vol. 8 ·2007-11-09 ·Pages 434

Lamy P, Andersen CL, Dyrskjot L, Torring N, Wiuf C

Abstract

Affymetrix SNP arrays can interrogate thousands of SNPs at the same time. This allows us to look at the genomic content of cancer cells and to investigate the underlying events leading to cancer. Genomic copy-numbers are today routinely derived from SNP array data, but the proposed algorithms for this task most often disregard the genotype information available from germline cells in paired germline-tumour samples. Including this information may deepen our understanding of the "true" biological situation e.g. by enabling analysis of allele specific copy-numbers. Here we rely on matched germline-tumour samples and have developed a Hidden Markov Model (HMM) to estimate allelic copy-number changes in tumour cells. Further with this approach we are able to estimate the proportion of normal cells in the tumour (mixture proportion). We show that our method is able to recover the underlying copy-number changes in simulated data sets with high accuracy (above 97.71%). Moreover, although the known copy-numbers could be well recovered in simulated cancer samples with more than 70% cancer cells (and less than 30% normal cells), we demonstrate that including the mixture proportion in the HMM increases the accuracy of the method. Finally, the method is tested on HapMap samples and on bladder and prostate cancer samples. The HMM method developed here uses the genotype calls of germline DNA and the allelic SNP intensities from the tumour DNA to estimate allelic copy-numbers (including changes) in the tumour. It differentiates between different events like uniparental disomy and allelic imbalances. Moreover, the HMM can estimate the mixture proportion, and thus inform about the purity of the tumour sample.

MeSH Terms
Algorithms Alleles DNA Mutational Analysis/methods DNA, Neoplasm/analysis Gene Dosage Genome, Human Genotype Humans Male Markov Chains Models, Statistical Neoplasms/diagnosis,genetics Oligonucleotide Array Sequence Analysis Polymorphism, Single Nucleotide Sensitivity and Specificity
Chemicals
DNA, Neoplasm
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Lamy Philippe
Bioinformatics Research Center, University of Aarhus, Hoegh-Guldbergsgade 10, Bldg 1090, 8000 Aarhus C, Denmark. plamy@birc.au.dk
Andersen Claus L
Dyrskjot Lars
Torring Niels
Wiuf Carsten
References (29)
29 references, click to expand
  1. CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays.
    BMC Bioinformatics. 2006 Feb 21;7:83 PMID: 16504045
  2. High-resolution analysis of DNA copy number using oligonucleotide microarrays.
    Genome Res. 2004 Feb;14(2):287-95 PMID: 14762065
  3. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis.
    Cancer Genet Cytogenet. 1999 Apr 15;110(2):87-93 PMID: 10214355
  4. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.
    Cancer Res. 2005 Jan 15;65(2):375-8 PMID: 15695375
  5. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.
    Cancer Res. 2003 Aug 15;63(16):4781-5 PMID: 12941794
  6. Genotyping and annotation of Affymetrix SNP arrays.
    Nucleic Acids Res. 2006;34(14):e100 PMID: 16899450
  7. Intratumoral nuclear morphologic heterogeneity in prostate cancer.
    Urology. 1997 Apr;49(4):652-7 PMID: 9111646
  8. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7012-22 PMID: 16203795
  9. Frequent occurrence of uniparental disomy in colorectal cancer.
    Carcinogenesis. 2007 Jan;28(1):38-48 PMID: 16774939
  10. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.
    Cancer Res. 2005 Jul 15;65(14):6071-9 PMID: 16024607
  11. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.
    Cancer Res. 2005 Jan 1;65(1):34-45 PMID: 15665277
  12. A genotype calling algorithm for affymetrix SNP arrays.
    Bioinformatics. 2006 Jan 1;22(1):7-12 PMID: 16267090
  13. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Clin Cancer Res. 2005 Nov 1;11(21):7709-19 PMID: 16278391
  14. Coverage and characteristics of the Affymetrix GeneChip Human Mapping 100K SNP set.
    PLoS Genet. 2006 May;2(5):e67 PMID: 16680197
  15. Large-scale genotyping of complex DNA.
    Nat Biotechnol. 2003 Oct;21(10):1233-7 PMID: 12960966
  16. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.
    Cancer Res. 2004 May 1;64(9):3060-71 PMID: 15126342
  17. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array.
    Br J Cancer. 2007 Feb 12;96(3):499-506 PMID: 17245344
  18. High-throughput SNP genotyping on universal bead arrays.
    Mutat Res. 2005 Jun 3;573(1-2):70-82 PMID: 15829238
  19. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
    PLoS Comput Biol. 2006 May;2(5):e41 PMID: 16699594
  20. Allele-specific amplification in cancer revealed by SNP array analysis.
    PLoS Comput Biol. 2005 Nov;1(6):e65 PMID: 16322765
  21. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data.
    Bioinformatics. 2004 May 22;20(8):1233-40 PMID: 14871870
  22. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays.
    Nat Methods. 2004 Nov;1(2):109-11 PMID: 15782172
  23. Whole-genome patterns of common DNA variation in three human populations.
    Science. 2005 Feb 18;307(5712):1072-9 PMID: 15718463
  24. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.
    Lab Invest. 2000 May;80(5):709-18 PMID: 10830781
  25. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.
    Prostate. 2007 May 15;67(7):692-700 PMID: 17342750
  26. Circular binary segmentation for the analysis of array-based DNA copy number data.
    Biostatistics. 2004 Oct;5(4):557-72 PMID: 15475419
  27. Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays.
    Bioinformatics. 2005 May 1;21(9):1958-63 PMID: 15657097
  28. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
    Scand J Urol Nephrol. 2005;39(5):387-92 PMID: 16257840
  29. Use of molecular variation in the NCBI dbSNP database.
    Hum Mutat. 2000;15(1):68-75 PMID: 10612825
Article Info
Journal
BMC bioinformatics
Abbr.
BMC Bioinformatics
ISSN
1471-2105
Published
2007-11-09
Epub
2007-00-09
Pages
434
Language
English
Region
England
NLM ID
100965194
PMCID
PMC2206057
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com